Muller Fabbri to Neoplasms
This is a "connection" page, showing publications Muller Fabbri has written about Neoplasms.
Connection Strength
2.918
-
Cocks A, Del Vecchio F, Martinez-Rodriguez V, Schukking M, Fabbri M. Pro-tumoral functions of tumor-associated macrophage EV-miRNA. Semin Cancer Biol. 2022 11; 86(Pt 1):58-63.
Score: 0.330
-
Cocks A, Martinez-Rodriguez V, Del Vecchio F, Schukking M, Broseghini E, Giannakopoulos S, Fabbri M. Diverse roles of EV-RNA in cancer progression. Semin Cancer Biol. 2021 10; 75:127-135.
Score: 0.317
-
Fabbri M. Natural Killer Cell-Derived Vesicular miRNAs: A New Anticancer Approach? Cancer Res. 2020 01 01; 80(1):17-22.
Score: 0.292
-
Vannini I, Fanini F, Fabbri M. Emerging roles of microRNAs in cancer. Curr Opin Genet Dev. 2018 02; 48:128-133.
Score: 0.259
-
Barbato S, Solaini G, Fabbri M. MicroRNAs in Oncogenesis and Tumor Suppression. Int Rev Cell Mol Biol. 2017; 333:229-268.
Score: 0.240
-
Fanini F, Fabbri M. Cancer-derived exosomic microRNAs shape the immune system within the tumor microenvironment: State of the art. Semin Cell Dev Biol. 2017 07; 67:23-28.
Score: 0.239
-
Frediani JN, Fabbri M. Essential role of miRNAs in orchestrating the biology of the tumor microenvironment. Mol Cancer. 2016 05 26; 15(1):42.
Score: 0.230
-
Challagundla KB, Fanini F, Vannini I, Wise P, Murtadha M, Malinconico L, Cimmino A, Fabbri M. microRNAs in the tumor microenvironment: solving the riddle for a better diagnostics. Expert Rev Mol Diagn. 2014 Jun; 14(5):565-74.
Score: 0.200
-
Fabbri M, Calore F, Paone A, Galli R, Calin GA. Epigenetic regulation of miRNAs in cancer. Adv Exp Med Biol. 2013; 754:137-48.
Score: 0.182
-
Fabbri M. miRNAs as molecular biomarkers of cancer. Expert Rev Mol Diagn. 2010 May; 10(4):435-44.
Score: 0.151
-
Valeri N, Vannini I, Fanini F, Calore F, Adair B, Fabbri M. Epigenetics, miRNAs, and human cancer: a new chapter in human gene regulation. Mamm Genome. 2009 Sep-Oct; 20(9-10):573-80.
Score: 0.144
-
Winkle M, El-Daly SM, Fabbri M, Calin GA. Noncoding RNA therapeutics - challenges and potential solutions. Nat Rev Drug Discov. 2021 08; 20(8):629-651.
Score: 0.082
-
Samuel P, Fabbri M, Carter DRF. Mechanisms of Drug Resistance in Cancer: The Role of Extracellular Vesicles. Proteomics. 2017 Dec; 17(23-24).
Score: 0.063
-
Guire V, Fabbri M, Tsongalis GJ. Not all good things come in big packages. Clin Chem Lab Med. 2017 05 01; 55(5):605-607.
Score: 0.061
-
Galli R, Paone A, Fabbri M, Zanesi N, Calore F, Cascione L, Acunzo M, Stoppacciaro A, Tubaro A, Lovat F, Gasparini P, Fadda P, Alder H, Volinia S, Filippini A, Ziparo E, Riccioli A, Croce CM. Toll-like receptor 3 (TLR3) activation induces microRNA-dependent reexpression of functional RAR? and tumor regression. Proc Natl Acad Sci U S A. 2013 Jun 11; 110(24):9812-7.
Score: 0.047
-
Fabbri M, Paone A, Calore F, Galli R, Croce CM. A new role for microRNAs, as ligands of Toll-like receptors. RNA Biol. 2013 Feb; 10(2):169-74.
Score: 0.045
-
Volinia S, Galasso M, Costinean S, Tagliavini L, Gamberoni G, Drusco A, Marchesini J, Mascellani N, Sana ME, Abu Jarour R, Desponts C, Teitell M, Baffa R, Aqeilan R, Iorio MV, Taccioli C, Garzon R, Di Leva G, Fabbri M, Catozzi M, Previati M, Ambs S, Palumbo T, Garofalo M, Veronese A, Bottoni A, Gasparini P, Harris CC, Visone R, Pekarsky Y, de la Chapelle A, Bloomston M, Dillhoff M, Rassenti LZ, Kipps TJ, Huebner K, Pichiorri F, Lenze D, Cairo S, Buendia MA, Pineau P, Dejean A, Zanesi N, Rossi S, Calin GA, Liu CG, Palatini J, Negrini M, Vecchione A, Rosenberg A, Croce CM. Reprogramming of miRNA networks in cancer and leukemia. Genome Res. 2010 May; 20(5):589-99.
Score: 0.038